Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (1y) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Operating Income Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Corbus Pharmaceuticals Holdings | 113.47 Mn | 85.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -57.48% |
| Jun 30, 2025 | 111.96% |
| Mar 31, 2025 | 63.52% |
| Dec 31, 2024 | 117.62% |
| Sep 30, 2024 | -63.42% |
| Jun 30, 2024 | -34.18% |
| Mar 31, 2024 | 105.94% |
| Dec 31, 2023 | 6.42% |
| Sep 30, 2023 | -15.97% |
| Jun 30, 2023 | 33.64% |
| Mar 31, 2023 | -103.08% |
| Dec 31, 2022 | -7.99% |
| Sep 30, 2022 | 41.04% |
| Jun 30, 2022 | 26.11% |
| Mar 31, 2022 | 44.74% |
| Dec 31, 2021 | 51.96% |
| Sep 30, 2021 | 59.16% |
| Jun 30, 2021 | 56.21% |
| Mar 31, 2021 | 48.42% |
| Dec 31, 2020 | 23.46% |